The role of alpha-lipoic acid in the treatment of dyslipidemia in patients with coronary artery disease

Allaeva M.J., Boboyev B.M., Achilov D.D.1, D.X Nuralieva2.

dc.contributor.author	Allaeva M.J., Boboyev B.M., Achilov D.D.1, D.X Nuralieva2.
dc.date.accessioned	2022-12-15T06:29:06Z
dc.date.available	2022-12-15T06:29:06Z
dc.date.issued	2022
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/5282
dc.description.abstract	Alpha-lipoic acid (ALA) is produced naturally in human organism. It plays an crucial role in lipid metabolism. It is also a cofactor of enzymes in carbohydrate metabolism. Recently, it has been shown that ALA supplementation might affect the lipid profile by influencing lipid metabolism. However, these findings remain controversial. The probable lipid-lowering mechanism might be explained by beneficial effects of ALA on mitochondrial fatty acid β-oxidation through activation of AMP-activated protein kinase.	en_US
dc.language.iso	other	en_US
dc.publisher	Uzbekistan, Termez	en_US
dc.subject	LIPOIC ACID,CORONARY ARTERY DISEASE,DYSLIPIDEMIA	en_US
dc.title	The role of alpha-lipoic acid in the treatment of dyslipidemia in patients with coronary artery disease	en_US
dc.type	Thesis	en_US